Daniel J DeAngelo - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Daniel J DeAngelo

Showing results (31-40 of 320) with videos related to

Pageof 32

Sort By:

Blood|September 11, 2004

After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignanciesMartha Wadleigh, Daniel J DeAngelo, James D Griffin, et al.

Cancer Genetics and Cytogenetics|September 15, 2005

Isochromosome of a deleted 20q may be a relatively common abnormality in myeloid malignanciesAzra H Ligon, Daniel J DeAngelo, Leonard Atkins, et al.

Blood Cancer Journal|November 4, 2025

Correspondence on: Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score-matched studyLuis E Aguirre, Richard M Stone, Daniel J DeAngelo, et al.

Journal of Clinical Pathology|August 11, 2018

Many faces of the same myeloid neoplasm: a case of leukaemia cutis with mixed histiocytic and Langerhans cell differentiationVignesh Shanmugam, Elizabeth A Morgan, Daniel J DeAngelo, et al.

British Journal of Clinical Pharmacology|December 12, 2018

Effect of inotuzumab ozogamicin on the QT interval in patients with haematologic malignancies using QTc-concentration modellingJennifer E Hibma, Hagop M Kantarjian, Daniel J DeAngelo, et al.

Histopathology|March 7, 2017

Morphological and immunophenotypical features of hairy cell leukaemia involving lymph nodes and extranodal tissuesJacqueline M Cortazar, Daniel J DeAngelo, Geraldine S Pinkus, et al.

The New England Journal of Medicine|June 6, 2008

Clinical problem-solving. A joint ventureAbraham B Schwarzberg, Cristina B Alexander, Daniel J DeAngelo, et al.

Leukemia & Lymphoma|September 16, 2024

Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidationEvan C Chen, Yael Flamand, Emily Tiao, et al.

Cancer Genetics and Cytogenetics|August 6, 2005

Is the cryptic interstitial deletion of 8q24 surrounding MYC a common mechanism in the formation of double minute chromosome?Nicole C Christacos, Leah Sherman, Alyssa Roy, et al.

Journal of Adolescent and Young Adult Oncology|September 25, 2024

Abatement of the Survival Cliff in Older Adolescents and Young Adults with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma in the United StatesArchie Bleyer, Eric Tai, Stuart Siegel, et al.

Pageof 32

Search research articles

Showing results (31-40 of 320) with videos related to

Sort By:

Pageof 32

Blood|September 11, 2004

After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignanciesMartha Wadleigh, Daniel J DeAngelo, James D Griffin, et al.

Cancer Genetics and Cytogenetics|September 15, 2005

Isochromosome of a deleted 20q may be a relatively common abnormality in myeloid malignanciesAzra H Ligon, Daniel J DeAngelo, Leonard Atkins, et al.

Blood Cancer Journal|November 4, 2025

Journal of Clinical Pathology|August 11, 2018

Many faces of the same myeloid neoplasm: a case of leukaemia cutis with mixed histiocytic and Langerhans cell differentiationVignesh Shanmugam, Elizabeth A Morgan, Daniel J DeAngelo, et al.

British Journal of Clinical Pharmacology|December 12, 2018

Effect of inotuzumab ozogamicin on the QT interval in patients with haematologic malignancies using QTc-concentration modellingJennifer E Hibma, Hagop M Kantarjian, Daniel J DeAngelo, et al.

Histopathology|March 7, 2017

Morphological and immunophenotypical features of hairy cell leukaemia involving lymph nodes and extranodal tissuesJacqueline M Cortazar, Daniel J DeAngelo, Geraldine S Pinkus, et al.

The New England Journal of Medicine|June 6, 2008

Clinical problem-solving. A joint ventureAbraham B Schwarzberg, Cristina B Alexander, Daniel J DeAngelo, et al.

Leukemia & Lymphoma|September 16, 2024

Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidationEvan C Chen, Yael Flamand, Emily Tiao, et al.

Cancer Genetics and Cytogenetics|August 6, 2005

Is the cryptic interstitial deletion of 8q24 surrounding MYC a common mechanism in the formation of double minute chromosome?Nicole C Christacos, Leah Sherman, Alyssa Roy, et al.

Journal of Adolescent and Young Adult Oncology|September 25, 2024

Abatement of the Survival Cliff in Older Adolescents and Young Adults with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma in the United StatesArchie Bleyer, Eric Tai, Stuart Siegel, et al.

Pageof 32